Leading cancer deaths in people younger than 50 years

JAMA

2026-01-22

(Press-News.org) About The Study: Mortality has decreased for every leading cancer-related death in people younger than 50 years in the U.S. except colorectal cancer, which is now the leading cancer death in females and males combined, up from the fifth-leading cancer death in the early 1990s. Breast cancer and leukemia mortality decreased despite increasing incidence.

Authors: Corresponding Author Rebecca Siegel, MPH, is available for interviews 11 AM-5 PM EST Tuesday, January 20. Senior Author Ahmedin Jemal, DVM, PhD, is available for the remainder of the embargo period. American Cancer Society Media Director Anne Reynolds-Doerr can be reached at anne.doerr@cancer.org to arrange interviews.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2025.25467)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.25467?guestAccessKey=5eabd609-08b0-47c7-a738-916c7acdcc37&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012226

END

ELSE PRESS RELEASES FROM THIS DATE:

Rural hospital bypass by patients with commercial health insurance

2026-01-22

About The Study: Rural hospital bypass (when rural residents receive care at hospitals other than their nearest hospital) rates among commercially insured patients were substantial between 2012 and 2021, generating large payments to receiving hospitals. Relative to Medicare bypass rates, commercial bypass rates were high in this sample. The findings of this study support concerns that commercial bypass contributes to financial distress at rural hospitals. Corresponding Author: To contact the corresponding author, Caitlin E. Carroll, PhD, email carrollc@umn.edu. To ...

Jumping giants: Fossils show giant prehistoric kangaroos could still hop

2026-01-22

Scientists studying the fossil remains of giant prehistoric kangaroos have found that even animals weighing more than 200kg may not have been too big to bounce, overturning long-held assumptions about the limits of hopping. Today, the red kangaroo is the largest living hopping animal and weighs around 90kg. But during the Ice Age, some kangaroos grew more than twice the size of that - some reaching up to 250kg. For years, researchers believed these giants must have abandoned hopping, as earlier studies suggested that hopping would become mechanically ...

Missing Medicare data alters hospital penalties, study finds

2026-01-22

For more than a decade, hospitals have worked to help older adults avoid repeated inpatient stays, incentivized by a federal program that cuts Medicare reimbursements if hospitals have higher-than-expected rates of readmissions for people with certain conditions. The Hospital Readmissions Reduction Program has helped spur innovation, including initiatives to better prepare patients and their families to manage care after hospitalization, and to support them virtually at home. But a new University of Michigan study finds that these financial penalties have hit some hospitals harder than they should, even if those hospitals have done a reasonable job at keeping people with heart ...

Experimental therapy targets cancer’s bodyguards, turning foe to friend to eliminate tumors

2026-01-22

[New York, NY [January 22, 2026]—Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it targets the cells that protect them. The study, published in the January 22 online issue of Cancer Cell, a Cell Press Journal [DOI 10.1016/j.ccell.2025.12.021], was conducted in aggressive preclinical models of metastatic ovarian and lung cancer. It points to a new strategy ...

Discovery illuminates how inflammatory bowel disease promotes colorectal cancer

2026-01-22

A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone marrow—may help explain why people with inflammatory bowel disease (IBD) have a higher risk of colorectal cancer, according to a preclinical study by Weill Cornell Medicine investigators. The findings point to new possibilities for diagnosis, monitoring and treatment. The study began with a focus on TL1A, an inflammatory immune signaling protein known to be associated with IBD and colorectal cancer. Experimental drugs that block TL1A activity have shown great promise against IBD in clinical trials, but how the signaling ...

Quality and quantity? The clinical significance of myosteatosis in various liver diseases

2026-01-22

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of poor clinical outcomes across a spectrum of liver diseases. However, the field faces significant challenges, including a lack of standardized assessment methods, definitions, and diagnostic criteria, as well as an incomplete understanding of its pathophysiological mechanisms. This narrative review aims to synthesize current knowledge on myosteatosis in liver disease, covering its assessment, clinical impact across various etiologies, proposed ...

Expert consensus on clinical applications of fecal microbiota transplantation for chronic liver disease (2025 edition)

2026-01-22

The gut microbiota plays a crucial role in maintaining host health and liver function. Fecal microbiota transplantation (FMT), an emerging therapeutic modality, has demonstrated promising potential in the treatment of chronic liver diseases. To assist clinicians in rapidly mastering and standardizing the clinical application of FMT for chronic liver disease, the Liver-Related Digestive Diseases Group of the Chinese Society of Hepatology, Chinese Medical Association, has developed this expert consensus. The consensus comprehensively addresses key aspects of FMT application, including indications, contraindications, efficacy, safety, donor selection ...

Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor fo

2026-01-22

Presentations include first-in-human Phase 1 results in healthy volunteers, 13-week repeat-dose toxicology in two species, and disease mitigation in a chronic T cell transfer-induced colitis model CAMBRIDGE, Mass. and SHANGHAI — January 22, 2026 — Insilico Medicine (“Insilico”, HKEX: 03696), a clinical-stage AI-driven biotechnology company, today announced it will present three abstracts at the 2026 Crohn’s & Colitis Congress 2026 in Las Vegas, USA on January 23, 2026 featuring new data supporting the continued development of ISM5411 (also referenced as ISM012-042), an orally administered, gut-restricted small-molecule ...

New imaging technology detects early signs of heart disease through the skin

2026-01-22

Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for invasive procedures. By revealing early signs of cardiovascular risk, this technology could help doctors intervene sooner, guide personalized therapies, and improve long-term heart health. A New Window Into Microvascular Health One of the earliest warning signs of cardiovascular disease ...

Resurrected ancient enzyme offers new window into early Earth and the search for life beyond it

2026-01-22

By resurrecting a 3.2-billion-year-old enzyme and studying it inside living microbes, researchers at the University of Wisconsin–Madison have created a new way to improve our understanding of the origins of life on Earth and possibly recognize signs of life elsewhere. Recently published in Nature Communications, the NASA-funded study uses synthetic biology to reverse-engineer modern enzymes and rebuild their possible ancestors. Betül Kaçar, a professor of bacteriology, and Holly Rucker, a PhD candidate in Kaçar’s lab, focused on an enzyme called nitrogenase, which is critical to the process that converts atmospheric nitrogen into a form usable by living ...

Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor fo

A cigarette compound-induced tumor microenvironment promotes sorafenib resistance in hepatocellular carcinoma via the 14-3-3η-modified tumor-associated proteome

Brain network disorders study provides insights into the role of molecular chaperones in neurodegenerative diseases

[Press-News.org] Leading cancer deaths in people younger than 50 years
JAMA

Leading cancer deaths in people younger than 50 years

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: